8IU intranasal oxytocin

DRUG2 trials

Sponsors

OptiNose AS

Conditions

Autism Spectrum DisorderHealthy Male Adults

Phase 1

Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults

CompletedNCT01983514

OptiNose ASHealthy Male Adults

Start: 2013-10-31End: 2014-02-28Updated: 2014-04-23

Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder

CompletedNCT02414503

OptiNose ASAutism Spectrum Disorder

Start: 2015-04-30End: 2016-02-29Updated: 2016-09-27

Related Papers

Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial.

2016-04-2279 citations